Pau Montesinos-rekin lankidetzan egindako argitalpenak (1)

2024

  1. A phase 2, multicenter, clinical trial of CPX-351 in older patients with secondary or high-risk acute myeloid leukemia: PETHEMA-LAMVYX

    Cancer